resurchify Conferences Journals Workshops Seminars
      
SYMPOSIUMS MEETINGS CONFERENCE RANKING JOURNAL RANKING IMPACT FACTOR BLOGS






Current Enzyme Inhibition - Impact Factor, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and other Important Metrics


Impact Factor

0.35

H-Index

15

Rank

21144

SJR

0.153

Note: The impact factor shown here is equivalent to citescore and is, therefore, used as a replacement for the same. Citescore is produced by Scopus, and can be a little higher or different compared to the impact factor produced by Journal Citation Report. Please refer to Web of Science data source for checking the exact journal impact factor ™ (Thomson Reuters) metric.

Title Current Enzyme Inhibition
Publication Type journal
Subject Area, Categories, Scope Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)
h-index 15
Overall Rank/Ranking 21144
SCImago Journal Rank (SJR) 0.153
Impact Factor 0.35
Publisher Bentham Science Publishers
Country United Arab Emirates
ISSN 15734080


About Current Enzyme Inhibition


Current Enzyme Inhibition is a journal covering the technologies/fields/categories related to Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4). It is published by Bentham Science Publishers. The overall rank of Current Enzyme Inhibition is 21144. According to SCImago Journal Rank (SJR), this journal is ranked 0.153. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 15. The best quartile for this journal is Q4.

The ISSN of Current Enzyme Inhibition journal is 15734080. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Current Enzyme Inhibition is cited by a total of 25 articles during the last 3 years (Preceding 2018).

Current Enzyme Inhibition Impact Factor 2018-2019


The impact factor (IF) 2018 of Current Enzyme Inhibition is 0.35, which is computed in 2019 as per it's definition. Current Enzyme Inhibition IF is decreased by a factor of 0.31 and approximate percentage change is -46.97% when compared to preceding year 2017, which shows a falling trend. The impact factor (IF), also denoted as Journal impact factor (JIF), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal.



Table Setting

Current Enzyme Inhibition Impact Factor 2019 Prediction


IF 2018 of Current Enzyme Inhibition is 0.35. If the same downward trend persists, impact factor of joule may fall in 2019 as well.

Current Enzyme Inhibition h-index


  Table Setting

Current Enzyme Inhibition has an h-index of 15. It means 15 articles of this journal have more than 15 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.

Current Enzyme Inhibition ISSN


The ISSN of Current Enzyme Inhibition is 15734080. ISSN stands for International Standard Serial Number. An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Current Enzyme Inhibition Rank and SCImago Journal Rank (SJR)


The overall rank of Current Enzyme Inhibition is 21144. According to SCImago Journal Rank (SJR), this journal is ranked 0.153. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

Current Enzyme Inhibition Publisher


Table Setting

Current Enzyme Inhibition is published by Bentham Science Publishers. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2006-ongoing. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.

How to publish in Current Enzyme Inhibition


If your research field is/are related to Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4), then you can visit the official website of the journal.

Acceptance Rate


To check the acceptance rate of this journal, visit here.

Call for Paper, Submission Guidelines, Notification Date, and Submission Deadline 2020/2019


Visit the official website of the journal/conference for the call for paper, submission guidelines, notification date, and submission deadlines.


Source: https://www.scimagojr.com/journalrank.php



Impact Factor, h-Index, and other important details of other Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Factor
Agypten und Levante journal 14513 Verlag der Osterreichischen Akademie der Wissenschaften 14 0.29
Muslim Minorities book series 28818 Entomological Society of Canada 5 0.80
Journal of Children and Media journal 6146 Routledge 10 1.75
Distance Education journal 4557 Carfax Publishing Ltd. 40 2.17
Journal of Applied Research in Memory and Cognition journal 2561 Elsevier BV 23 3.35
Proceedings - SDEMPED 2015: IEEE 10th International Symposium on Diagnostics for Electrical Machines, Power Electronics and Drives conference and proceedings 15423 7 0.00
Annals of Thoracic and Cardiovascular Surgery journal 10719 Nihon Akuseru Shupuringa Shuppan K.K./Axel Springer 38 1.15
International Journal of Knowledge and Systems Science journal 24718 IGI Global Publishing 2 0.50
HP Laboratories Technical Report journal 30181 Hewlett-Packard Company 20 0.00
Journal of Hepato-Biliary-Pancreatic Sciences journal 3573 Wiley-Blackwell 46 2.42

Check complete list

Year wise Impact Factor (IF) of Current Enzyme Inhibition

Year Impact Factor (IF)
2019Coming Soon
20180.35
20170.66
20160.38
20150.27
20140.52



Top Journals/Conferences in Biochemistry

Cell
Cell Press | United States

Nature Methods
Nature Publishing Group | United Kingdom

Annual Review of Biochemistry
Annual Reviews Inc. | United States

Nature Medicine
Nature Publishing Group | United Kingdom

Annual Review of Biophysics
Annual Reviews Inc. | United States

Nature Protocols
Nature Publishing Group | United Kingdom

Trends in Biochemical Sciences
Elsevier BV | Netherlands

EMBO Journal
Wiley-Blackwell | Germany

Cold Spring Harbor perspectives in biology
Cold Spring Harbor Laboratory Press | United States

Journal of the American Chemical Society
American Chemical Society | United States


Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Molecular Therapy
Cell Press | United States

Cell Chemical Biology
Elsevier Inc. | United States

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Current Opinion in Pharmacology
Elsevier BV | Netherlands

Journal of Medicinal Chemistry
American Chemical Society | United States

Protein & Cell
Springer Verlag | Germany

Drug Discovery Today
Elsevier BV | Netherlands

Vaccines
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland


Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central | United Kingdom

EMBO Molecular Medicine
John Wiley & Sons Ltd. | United Kingdom

Trends in Molecular Medicine
Elsevier BV | Netherlands

Journal for ImmunoTherapy of Cancer
BioMed Central | United Kingdom

Molecular Therapy
Cell Press | United States

Molecular Cancer
BioMed Central | United Kingdom

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom